Related Experiment Video
Updated: May 5, 2026
The Resident-intruder Paradigm: A Standardized Test for Aggression, Violence and Social Stress
Published on: July 4, 2013
Clinical research: protection of the "vulnerable"?
Stephanie S Park1, Mitchell H Grayson
1Division of Allergy and Immunology, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO 63110, USA.
Abstract:
In this age of evidence-based medicine, clinical research is critical for developing new therapeutics and determining the best way to use these therapies. To perform appropriate clinical research, researchers must adhere to ethical standards. These standards have developed in large part as a response to egregious violations of ethically appropriate behavior. In this respect certain populations have been identified as at risk of being treated inappropriately in medical research. Current ethical guidelines prohibit or severely limit what types of research can be performed involving these "vulnerable" populations. Although this might protect these populations, the lack of research on them might actually do harm in limiting their access to life-saving therapies. We explore the historical underpinnings of protecting the vulnerable populations and whether a newer ethical paradigm that would allow for protected research on these populations should be adopted by society.
Insights
Protecting vulnerable populations in clinical research is crucial. Current ethical guidelines may inadvertently harm these groups by limiting access to potentially life-saving therapies, necessitating a review of research paradigms.
Area of Science:
- Medical Ethics
- Clinical Research
- Public Health
Background:
- Evidence-based medicine relies on robust clinical research.
- Ethical standards in research evolved from past misconduct.
- Vulnerable populations require specific ethical considerations.
Observation:
- Current ethical guidelines restrict research on vulnerable populations.
- These restrictions aim to prevent exploitation.
- Lack of research may deny vulnerable groups access to novel treatments.
Findings:
- Historical ethical violations led to stringent protections for vulnerable groups.
- Overly strict guidelines may create a research gap for these populations.
- This gap can hinder the development of tailored therapies.
Implications:
- Revisiting ethical frameworks is necessary for inclusive clinical research.
- A balanced approach could protect vulnerable populations while enabling vital research.
- This may improve health equity and therapeutic access for all individuals.
Related Concept Videos
01:56Ethics in Research
01:11Blinding
01:22Ethics and Bioethics
01:23Ethical Standards II
Nurses are entrusted with upholding various ethical principles and standards. Nurses forge solid therapeutic relationships using trust, empathy, autonomy, confidentiality, and professional competence.
Confidentiality is crucial, embodying respect for individual privacy...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients